Last reviewed · How we verify
Feminizing hormone therapy
Feminizing hormone therapy is a Small molecule drug developed by Asociación Civil Impacta Salud y Educación, Peru. It is currently FDA-approved.
At a glance
| Generic name | Feminizing hormone therapy |
|---|---|
| Sponsor | Asociación Civil Impacta Salud y Educación, Peru |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Feminizing Hormone Therapy and the Rectal Mucosa Immune Environment in Transgender Women
- Evaluation of Gender-Affirming Treatments on Pulmonary Function in Transgender and Gender Diverse Patients (NA)
- Feminizing Treatment in Transgender Women and Non-binary Persons
- Assessment of Drug-drug Interactions Between Feminizing Hormone Therapy and Emtricitabine/Tenofovir Alafenamide Concomitantly for Pre-exposure Prophylaxis Among Transgender Women (NA)
- China Gender-affirming Hormone Therapy Study
- Drug-Drug Interaction Study in Trans Women Living With HIV (PHASE4)
- Protocol TRANS and QT Repolarization
- A Pharmacokinetic Evaluation of Tenofovir/Emtricitabine as HIV Pre-Exposure Prophylaxis in Transgender Women (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Feminizing hormone therapy CI brief — competitive landscape report
- Feminizing hormone therapy updates RSS · CI watch RSS
- Asociación Civil Impacta Salud y Educación, Peru portfolio CI
Frequently asked questions about Feminizing hormone therapy
What is Feminizing hormone therapy?
Feminizing hormone therapy is a Small molecule drug developed by Asociación Civil Impacta Salud y Educación, Peru.
Who makes Feminizing hormone therapy?
Feminizing hormone therapy is developed and marketed by Asociación Civil Impacta Salud y Educación, Peru (see full Asociación Civil Impacta Salud y Educación, Peru pipeline at /company/asociaci-n-civil-impacta-salud-y-educaci-n-peru).
What development phase is Feminizing hormone therapy in?
Feminizing hormone therapy is FDA-approved (marketed).
Related
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing